ITRASPORAX 200 CAP delivers a higher dose of Itraconazole, a broad-spectrum triazole antifungal agent known for its efficacy in treating a wide range of fungal infections. It inhibits fungal cytochrome P450 enzymes, impairing ergosterol synthesis — a key component of fungal cell membranes — leading to fungal cell death.
ITRASPORAX 200 CAP is prescribed when a stronger, more concentrated antifungal treatment is required, particularly in:
Systemic fungal infections like histoplasmosis, aspergillosis, and blastomycosis
Fungal infections of nails (onychomycosis) and skin
Oral, esophageal, and vaginal candidiasis
Fungal infections resistant to topical treatment
Fungal infections in immunocompromised patients
With superior tissue penetration and a long half-life, ITRASPORAX 200 CAP ensures sustained therapeutic levels in the body. It is especially effective in pulse therapy, where higher intermittent dosing is required for difficult-to-treat infections like nail fungus.
This product is manufactured under international standards, including WHO-GMP, ISO, and DCGI compliance. It is suitable for bulk orders, private labeling, and registration in multiple regulated and semi-regulated markets across the globe, exclusively via BLUEPILL EXPRESS.
Contains Itraconazole 200 mg – high-potency antifungal
Designed for severe and systemic fungal infections
Suitable for pulse therapy and long-duration treatments
Excellent tissue penetration and antifungal activity
Manufactured under WHO-GMP certified facilities
Offered by BLUEPILL EXPRESS for global export and contract manufacturing
Flexible packaging and documentation support for international partners
Description provided by bluepill express.
FIEO Registered
Export Ready
